(Q62033166)
Statements
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL (English)
0 references
29 May 2009
0 references
256
0 references
6
0 references
1035-1037
0 references